Estimation of the Diaphragm Electrical Activity and Intercostal Thickening Fraction During Different Pattern of Mechanical Ventilation: PSV Versus NAVA
Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Aug 11, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of helping patients breathe when they are on a machine called a ventilator. Specifically, it is comparing a standard method called Pressure Support Ventilation (PSV) with a newer method called Neurally Adjusted Ventilatory Assist (NAVA). The goal is to see which method helps patients wean off the ventilator more effectively, particularly those who have had trouble doing so in the past. Researchers will look at how well the diaphragm, the main muscle used for breathing, is working during these different methods.
To participate in this trial, patients must be between 65 and 74 years old and have tried to stop using the ventilator at least once without success. They should have been on the ventilator for at least 24 hours. However, pregnant women, those with obesity (a Body Mass Index over 35), or certain muscle diseases cannot participate. If eligible, participants will undergo tests that measure their breathing muscles while using either PSV or NAVA. This study aims to improve care for patients with respiratory failure by finding out which method helps them breathe better and recover faster.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients who have failed at least one weaning attempt
- • mechanical ventilation for at least 24 hours
- Exclusion Criteria:
- • Pregnancy
- • Obesity (Body Mass Index \> 35 kg/m2)
- • Contraindication to the insert of a nasogastric tube
- • Neuromuscular diseases
About Fondazione Policlinico Universitario Agostino Gemelli Irccs
Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a leading research and healthcare institution based in Rome, Italy, renowned for its commitment to advancing medical science and improving patient care. As a prominent academic medical center affiliated with the Catholic University of the Sacred Heart, it integrates clinical practice, education, and research, fostering innovation in various fields of medicine. The foundation conducts a wide range of clinical trials aimed at developing new therapies and enhancing treatment protocols, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Its multidisciplinary approach and dedication to high ethical standards position it as a key player in the landscape of clinical research and healthcare improvement in Italy and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rome, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported